Search results
Discover historical prices for AKBA stock on Yahoo Finance. View daily, weekly or monthly format back to when Akebia Therapeutics, Inc. stock was issued.
2 days ago · What is the target price for Akebia Therapeutics (AKBA) stock? A The latest price target for Akebia Therapeutics ( NASDAQ : AKBA ) was reported by HC Wainwright & Co. on Thursday, March 28, 2024 .
Akebia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target AKBA. High $ 6.00: Median $ 5.00: Low $ 4.00: Average $ 5.00: Current Price ...
May 17, 2024 · A high-level overview of Akebia Therapeutics, Inc. (AKBA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive ...
Akebia Therapeutics, Inc. Common Stock (AKBA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.
5 days ago · 2007. 167. John Butler. www.akebia.com. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company’s lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is ...
